Search Results - "Pusterla, L"

The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study by Bonfanti, P., Pusterla, L., Parazzini, F., Libanore, M., Cagni, A.E., Franzetti, M., Faggion, I., Landonio, S., Quirino, T.

“…Our study was undertaken to evaluate if desensitization treatment is more effective than rechallenge in preventing hypersensitivity reactions in HIV-positive…”
Get full text

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients by Quirino, T, Niero, F, Ricci, E, Pusterla, L, Carradori, S, Gabbuti, A, Iemoli, E, Landonio, S, Faggion, I, Bonfanti, P

“…The aim of our study is to compare the tolerability of zidovudine/lamivudine/indinavir when used in post-exposure prophylaxis (PEP) subjects and in…”
Get full text

Osteonecrosis in protease inhibitor-treated patients by Bonfanti, P, Grabbuti, A, Carradori, S, Pusterla, L, Parrazini, F, Landonio, S, Quirino, T

“…The introduction of protease inhibitors has proven a watershed in human immunodeficiency virus infection therapy and has initiated an era of highly active…”
Get full text

Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity by Quirino, T., Bonfanti, P., Arcidiacono, M., Pusteria, L., Cagni, A., Scaglione, F., Milazzo, F.

“…This trial was conducted to study the frequency of the slow acetylator phenotype in asymptomatic HIV patients having no previous reaction to sulfa-drugs, and…”
Get full text

Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network by Aghemo, A, Bruno, R, Colombo, M, Medagli, M, Puoti, M, Rizzardini, G, Fagiuoli, S

“…The arrival of potent directly acting antivirals (DAAs) for the treatment of chronic Hepatitis C virus (HCV) infection was a challenge for the regional health…”
Get more information

Incidence of adverse reactions in HIV patients treated with protease inhibitors : A Cohort Study by BONFANTI, P, VALSECCHI, L, DI CINTIO, E, MARTINELLI, C, FAGGION, I, LANDONIO, S, QUIRINO, T, PARAZZINI, F, CARRADORI, S, PUSTERLA, L, FORTUNA, P, TIMILLERO, L, ALESSI, F, GHISELLI, G, GABBUTI, A

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Open, randomized, multicentre Italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART by CARGNEL, Antonietta, ANGELI, Elena, MAININI, Annalisa, GUBERTINI, Guido, GIORGI, Riccardo, SCHIAVINI, Monica, DUCA, Piergiorgio

“…Chronic hepatitis C is common and aggressive in HIV-positive patients, so the development of a well-tolerated HCV therapy is a priority. We evaluated the…”
Get full text

POLMONITI DA COXIELLA BURNETII: SEGNALAZIONE DI UN’EPIDEMIA IN PROVINCIA DI COMO by L. Pusterla, E. Sala, M. Spinelli, S. Savio, S. Cimetti, A. Gangemi, A. Maspero, R. Giura, O. Gandola, G. Gridavilla, E. Longoni, D. Santoro, G. Giana

Get full text

Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals by ANTONUCCI, Giorgio, GIRARDI, Enrico, LALLE, Eleonora, IPPOLITO, Giuseppe, D'ARMINIO MONFORTE, Antonella, COZZI-LEPRI, Alessandro, CAPOBIANCHI, Maria Rosaria, MORSICA, Giulia, PIZZAFERRI, Paolo, LADISA, Nicoletta, SIGHINOLFI, Laura, CHIODERA, Alessandro, SOLMONE, Mariacarmela

“…The prognostic role of GB virus type C (GBV-C) viraemia in HIV-infected subjects treated with highly active antiretroviral therapy (HAART) is still undefined…”
Get full text

Risk factors for lipodystrophy in the CISAI cohort by Bonfanti, Paolo, Gulisano, Cecilia, Ricci, Elena, Timillero, Lia, Valsecchi, Laura, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Miccolis, Sebastiano, Magnani, Carlo, Gabbuti, Andrea, Parazzini, Fabio, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana, Vigevani, GianMarco

“…Purpose. – This study set out to describe the frequency of lipodystrophy, and identify its risk factors, in HIV-positive patients treated with HAART containing…”
Get full text

Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems by DE LUCA, Andrea, COZZI-LEPRI, Alessandro, CHIODO, Francesco, MAGNANI, Giacomo, D'ARMINIO MONFORTE, Antonella, PERNO, Carlo-Federico, BALOTTA, Claudia, DI GIAMBENEDETTO, Simona, POGGIO, Antonio, PAGANO, Gabriella, TOSITTI, Giulia, PISCOPO, Rita, DEL FORNO, Antonio

“…High level HIV-1 drug resistance in recently infected treatment-naive individuals correlates with sub-optimal virological responses to highly active…”
Get full text

2.3 Prevalence of the Metabolic Syndrome in HIV Patients by Bonfanti, P, Giannattasio, C, Ricci, E, Facchetti, R, Capra, A, Citterio, F, Rosella, E, Franzetti, M, Cordier, L, Pusterla, L, Bombelli, M, Sega, R, Quirino, T, Mancia, G

Get full text

Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy by SOLMONE, Mariacarmela, GIRARDI, Enrico, ANTONUCCI, Giorgio, IPPOLITO, Giuseppe, CAPOBIANCHI, Maria R, LALLE, Eleonora, ABBATE, Isabella, D'ARMINIO MONFORTE, Antonella, COZZI-LEPRI, Alessandro, ALESSANDRINI, Anna, PISCOPO, Rita, EBO, Francesca, COSCO, Lucio

“…Hepatitis C virus (HCV) variability is mainly attributed to the ability of the virus to respond to host immune pressure, acting as a driving force for the…”
Get full text

Prevalence of the Metabolic Syndrome in HIV Patients by Bonfanti, P, Giannattasio, C, Ricci, E, Facchetti, R, Capra, A, Citterio, F, Rosella, E, Franzetti, M, Cordier, L, Pusterla, L, Bombelli, M, Sega, R, Quirino, T, Mancia, G

Get full text

The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug? by PUOTI, Massimo, COZZI-LEPRI, Alessandro, D'ARMINIO MONFORTE, Antonnella, ANCARANI, Fausto, BRUNO, Raffaele, AMBU, Silvia, FERRARO, Teresa, TUNDO, Paolo, SANTANTONIO, Teresa, TOTI, Mario, BONASSO, Marino

“…We examined the impact of a lamivudine-containing highly active antiretroviral therapy (HAART) regimen on 164 hepatitis B virus/HIV co-infected individuals…”
Get full text

Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction by Knippel, M, Bana, G, Pusterla, G L

“…Two groups of 23 patients, each with acute myocardial infarction, were treated. The first group (control) received glucose-insuline-K+ (GIK) over a 3-day…”
Get more information

The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group by Bonfanti, P, Pusterla, L, Parazzini, F, Libanore, M, Cagni, A E, Franzetti, M, Faggion, I, Landonio, S, Quirino, T

“…Our study was undertaken to evaluate if desensitization treatment is more effective than rechallenge in preventing hypersensitivity reactions in HIV-positive…”
Get full text

The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX : a randomized multicentric study : 1999-2000 Special AIDS issue by BONFANTI, P, PUSTERLA, L, PARAZZINI, F, LIBANORE, M, CAGNI, A. E, FRANZETTI, M, FAGGION, I, LANDONIO, S, QUIRINO, T

Get full text

Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group by Bonfanti, P, Valsecchi, L, Parazzini, F, Carradori, S, Pusterla, L, Fortuna, P, Timillero, L, Alessi, F, Ghiselli, G, Gabbuti, A, Di Cintio, E, Martinelli, C, Faggion, I, Landonio, S, Quirino, T

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Migrants' admissions to hospital : A retrospective study in Como from 1994 to 1998 by SANTORO, Domenico, VISONA, Raffaella, PUSTERLA, Luigi, VIGEVANI, Gian Marco

“…International migrants represent only 4.5% of the world's population, but they may become a challenge for host countries. The aim of the study was to assess…”
Get full text